Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-05-17 @ 11:01 PM
Study NCT ID:
NCT05474560
Status:
COMPLETED
Last Update Posted:
2023-08-01
First Post:
2022-07-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients
Sponsor:
Ain Shams University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Febuxostat versus allopurinol
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None